You are here

  • Home
  • Archive
  • Volume 8, Issue 5
  • Second-generation antipsychotic medications and risk of chronic kidney disease in schizophrenia: population-based nested case–control study

Article metrics

Article menu

Download PDFPDF

XML
Epidemiology
Research
Second-generation antipsychotic medications and risk of chronic kidney disease in schizophrenia: population-based nested case–control study

 

Online download statistics by month:

Online download statistics by month: May 2018 to April 2025

AbstractFullPdf
May 201836836943
Jun 201874174084
Jul 201817617615
Aug 201818518414
Sep 201817317313
Oct 201822122112
Nov 201824324320
Dec 201815515511
Jan 20191871856
Feb 20191641616
Mar 201920319911
Apr 201921821628
May 201921921515
Jun 201923323212
Jul 201922722515
Aug 201919219214
Oct 20191791789
Nov 201917817617
Dec 201922422213
Jan 20202172159
Feb 20202202197
Mar 20201901909
May 202016816740
Jun 202012212211
Jul 202020020010
Aug 202011711230
Sep 202013112230
Oct 202021721423
Nov 202014413913
Dec 202015515211
Jan 202113713512
Feb 202112212011
Mar 202121520524
Apr 202114814019
May 202117417717
Jun 202115315211
Jul 202114314310
Aug 202111711612
Sep 2021929212
Oct 2021706527
Nov 2021928730
Dec 2021899615
Jan 2022737221
Feb 202248508
Mar 2022737112
Apr 2022646111
May 2022645520
Jun 2022786715
Jul 202251517
Aug 2022564913
Sep 2022514619
Oct 2022645715
Nov 2022675712
Dec 202249527
Jan 2023675711
Feb 2023686918
Mar 2023817714
Apr 202384878
May 202311411416
Jun 2023736713
Jul 2023949316
Aug 202360639
Sep 202374769
Oct 2023798311
Nov 202379808
Dec 202350519
Jan 202432327
Feb 202432347
Mar 2024696546
Apr 2024555318
May 2024625815
Jun 2024717112
Jul 2024666814
Aug 2024868923
Sep 2024616920
Oct 2024605713
Nov 202449476
Dec 2024464611
Jan 2025535020
Feb 2025413715
Mar 2025535012
Apr 2025221818
Total10438102911310